D-1145-2022 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- June 22, 2022
- Initiation Date
- May 6, 2022
- Termination Date
- August 14, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4625 syringes
Product Description
medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL, Rx only, Manufactured by Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 62756-091-40.
Reason for Recall
Lack of assurance of sterility
Distribution Pattern
USA Nationwide
Code Information
Lot #: HAC1951A, Exp 06/2023